astilbin has been researched along with Bone Loss, Osteoclastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Chu, F; Jin, H; Kenny, J; Pan, H; Qiu, H; Tickner, J; Wang, C; Wang, Q; Wang, T; Wang, Z; Xu, H; Xu, J; Xu, K; Ye, Z | 1 |
1 other study(ies) available for astilbin and Bone Loss, Osteoclastic
Article | Year |
---|---|
Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Topics: Animals; Bone Resorption; Cells, Cultured; Drugs, Chinese Herbal; Female; Flavonols; Gene Expression; Humans; Integrin beta3; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; Phytotherapy; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells; Tartrate-Resistant Acid Phosphatase | 2019 |